ENTITY

Transgene SA (TNG FP)

Analysis

Health Care • France

Transgene S.A is a biotechnology company. The Company develops therapeutic vaccines and oncolytic viruses against solid tumors (lung, liver, head & neck and colorectal cancers). In addition to clinical-stage immunotherapies, Transgene S.A. develops individualized therapeutic vaccines and multi-functional oncolytic viruses.

Refresh

Company Event • 08 Nov 2024 00:45 • Upcoming

Add To Calendar

Q3 2024

Company Event • 14 Oct 2024 21:30 • Latest

Study Update

Company Event • 25 Sep 2024 00:00

H1 2024

Company Event • 01 Aug 2024 14:00 • Upcoming

Add To Calendar

Corporate Presentation

Company Event • 03 Jun 2024 16:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00